---
figid: PMC12110123__diseases-13-00143-g005
figtitle: 'Anticancer Mechanisms of Ginsenoside Compound K: A Review'
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC12110123
filename: diseases-13-00143-g005.jpg
figlink: /pmc/articles/PMC12110123/figure/F5/
number: F5
caption: Ginsenoside CK reduces the binding of SDF-1 to CXCR4, thereby inhibiting
  the activation of PKC-α and ERK, resulting in a decreased expression of MMP2 and
  MMP9 proteases downstream in the signaling pathway
papertitle: 'Anticancer Mechanisms of Ginsenoside Compound K: A Review'
reftext: Yu-Po Lee, et al. Diseases. 2025 May;13(5).
year: '2025'
doi: 10.3390/diseases13050143
journal_title: Diseases
journal_nlm_ta: Diseases
publisher_name: Multidisciplinary Digital Publishing Institute  (MDPI)
keywords: cancer | ginsenoside compound K | stromal cell-derived factor 1 | angiogenesis
  | chronic inflammation
automl_pathway: 0.9394803
figid_alias: PMC12110123__F5
figtype: Figure
redirect_from: /figures/PMC12110123__F5
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC12110123__diseases-13-00143-g005.html
  '@type': Dataset
  description: Ginsenoside CK reduces the binding of SDF-1 to CXCR4, thereby inhibiting
    the activation of PKC-α and ERK, resulting in a decreased expression of MMP2 and
    MMP9 proteases downstream in the signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CXCL12
  - CXCR4
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PRKCA
  - EPHB2
  - MMP9
  - MMP2
  - Nucleus
  - Cancer
---
